Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis

Affiliations

• ¹ Department of Pharmacy, Clinical Programs, Memorial Sloan Kettering Cancer, New York, NY, USA.
• ² Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ³ Department of Pharmacy, Clinical Programs, Vanderbilt University Medical Center, Nashville, TN, USA.
• ⁴ Department of Nursing, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁵ Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: steine@mskcc.org.